News Focus
News Focus
icon url

Hoskuld

10/29/24 7:31 PM

#472429 RE: Hosai #472427

ChatGPT is useless here. Not only is it low value-add, it is actually misleading. It is a real disservice to those who don't know how things work.
icon url

12x

10/29/24 8:06 PM

#472434 RE: Hosai #472427

According to CTAD program, Marwan is scheduled to present on Lecanemab treatment at 3:30 pm on 10/30. It looks like he’ll run the ‘ask the expert’ session (which isn’t shown on the program) at 12:45 pm on A2-73, then present Lecanemab at 3:30, followed by another A2-73 presentation at 9 am the next morning?

3:30 p.m. LATE BREAKING SYMPOSIUM 2 - One-Year Experience on the Use of Lecanemab in Clinical Practice
Co-chairs: Lefkos Middleton, ICL - London (United Kingdom), Bruno Vellas, IHU HealthAge - Toulouse (France)
Presentation 1: Lecanemab Treatment in Real World Settings in the United States
Marwan Sabbagh, Department of Neurology Barrow Neurological Institute - Phoenix, Arizona (United States)

icon url

rx7171

10/30/24 2:09 AM

#472452 RE: Hosai #472427

Anavex appears to be putting a lot of effort into priming the pump for the presentation the next day.
If they are presenting nothing of great interest why are they going to this effort just to fall on their face?